Article
Using Mendelian randomization provides genetic insights into potential targets for sepsis treatment
11 Apr 2024
Abstract excerpt
Sepsis is recognized as a major contributor to the global disease burden, but there is a lack of specific and effective therapeutic agents. Utilizing Mendelian randomization (MR) methods alongside evidence of causal genetics presents a chance to discover novel targets for therapeutic intervention. MR approach was employed to investigate potential drug targets for sepsis. Pooled statistics from IEU-B-4980...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
